BGLAP and neoplasm: Osteocalcin levels were generally lower in tumour-bearing mice, though the difference was not statistically significant and treatment of these mice with 20 (p<0.01) or 100 μg/kg (p<0.01) of ZOL further reduced the serum osteocalcin compared to the normal controls (Figure 2A).